Blastic plasmacytoid dendritic cell neoplasm: A report of four cases and review of the literature

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 9, 2013, Pages 1176-1181

  Borchiellini, D ^a   Ghibaudo, N ^a   Mounier, N ^a   Del Giudice, P ^b   Quinsat, D ^c   Ticchioni, M ^a   Perrin, C ^d   Cardot Leccia, N ^d   Lacour, J P ^b  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b Department of Obstetrics   (France)

^c Antibes Hospital   (France)

^d PASTEUR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; IDARUBICIN; MEPREDNISONE; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; CYTOGENETICS; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPERITONEUM; HEPATOMEGALY; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PAPULE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; REVIEW; SKIN BIOPSY; SKIN DEFECT; SPLEEN HEMATOMA; SPLENOMEGALY; TUMOR BIOPSY;

AGED; DENDRITIC CELLS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 84881132770     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04503.x     Document Type: Review

References (31)

1. Adachi M, Maeda K, Takekawa M, et al. High expression of CD56 (N-CAM) in a patient with cutaneous CD4-positive lymphoma. Am J Hematol 1994; 47: 278-282.
2. Petrella T, Comeau MR, Maynadie M, et al. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002; 26: 852-862.
3. Chan J, Jaffe E, Ralfkiaer E,. Blastic NK-cell lymphoma. In, Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumors Pathology & Genetics Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, London, 2001: 22-25.
4. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-3785.
5. Swerdlow S, Campo E, Harris N,. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue, 4th edn. World Health Organization, Geneva, 2008.
6. Dalle S, Beylot-Barry M, Bagot M, et al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol 2010; 162: 74-79.
7. Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a review. Am J Clin Pathol 2005; 123: 662-675.
8. Bekkenk MW, Jansen PM, Meijer CJ, Willemze R,. CD56+ hematological neoplasms presenting in the skin: a retrospective analysis of 23 new cases and 130 cases from the literature. Ann Oncol 2004; 15: 1097-1108.
9. Suzuki R, Nakamura S, Suzumiya J, et al. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement. Cancer 2005; 104: 1022-1031.
10. Yamaguchi M, Maekawa M, Nakamura Y, Ueda M,. Long-term remission of blastic natural killer-cell lymphoma after autologous peripheral blood stem-cell transplantation. Am J Hematol 2005; 80: 124-127.
11. Murashige N, Kami M, Kishi Y, et al. Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. Br J Haematol 2005; 130: 561-567.
12. Suzuki R, Suzumiya J, Nakamura S, et al. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplant 2006; 37: 425-431.
13. Petrella T, Dalac S, Maynadie M, et al. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Francais d'Etude des Lymphomes Cutanes (GFELC). Am J Surg Pathol 1999; 23: 137-146.
14. Lúcio P, Parreira A, Orfao A,. CD123hi dendritic cell lymphoma: an unusual case of non-Hodgkin lymphoma. Ann Intern Med 1999; 131: 549-550.
15. Trimoreau F, Donnard M, Turlure P, Gachard N, Bordessoule D, Feuillard J,. The CD4+ CD56+ CD116- CD123+ CD45RA+ CD45RO- profile is specific of DC2 malignancies. Haematologica 2003; 88: ELT10.
16. Chaperot L, Bendriss N, Manches O, et al. Identification of a leukemic counterpart of the plasmacytoid dendritic cells. Blood 2001; 97: 3210-3217.
17. Rossi J, Felice M, Bernasconi A, et al. Acute leukemia of dendritic cell lineage in childhood: incidence, biological characteristics and outcome. Leuk Lymphoma 2006; 47: 715-725.
18. Feuillard J, Jacob MC, Valensi F, et al. Clinical and biologic features of CD4(+)CD56(+) malignancies. Blood 2002; 99: 1556-1563.
19. Bueno C, Almeida J, Lucio P, et al. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies. Haematologica 2004; 89: 58-69.
20. Wang H, Cao J, Hong X,. Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review. Acta Haematol 2012; 127: 124-127.
21. Rauh MJ, Rahman F, Good D, et al. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: case series and literature review. Leuk Res 2012; 36: 81-86.
22. Dantas FE, de Almeida Vieira CA, de Castro CC, Neto GC, Matos DM,. Blastic plasmacytoid dendritic cell neoplasm without cutaneous involvement: a rare disease with a rare presentation. Acta Oncol 2012; 51: 139-141.
23. Choi KW, Lee KY, Lee YK, et al. CD4-/CD56+/CD123+ hematodermic neoplasm showing early liver metastasis. Ann Dermatol 2010; 22: 186-190.
24. Prematilleke I, Mohan V, Roberts I, Protheroe A, Gatter K,. Blastic plasmacytoid dendritic cell neoplasm presenting as a renal mass. Histopathology 2011; 59: 799-801.
25. Niakosari F, Sur M,. Agranular CD4+/CD56+ hematodermic neoplasm: a distinct entity described in the recent World Health Organization-European organization for research and treatment of cancer classification for cutaneous lymphomas. Arch Pathol Lab Med 2007; 131: 149-151.
26. Marafioti T, Paterson JC, Ballabio E, et al. Novel markers of normal and neoplastic human plasmacytoid dendritic cells. Blood 2008; 111: 3778-3792.
27. Jegalian AG, Facchetti F, Jaffe ES,. Plasmacytoid dendritic cells: physiologic roles and pathologic states. Adv Anat Pathol 2009; 16: 392-404.
28. Petrella T, Facchetti F,. Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009? Autoimmunity 2010; 43: 210-214.
29. Ferran M, Gallardo F, Ferrer A, et al. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge. Br J Dermatol 2008; 158: 1129-1133.
30. Bénet C, Gomez A, Aguilar C, et al. Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 cases. Am J Clin Pathol 2011; 135: 278-290.
31. Dietrich S, Andrulis M, Hegenbart U, et al. Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity. Biol Blood Marrow Transplant 2011; 17: 1250-1254.